Persistent Asset Partners LTD Regeneron Pharmaceuticals, Inc. Transaction History
Persistent Asset Partners LTD
- $135 Billion
- Q2 2025
A detailed history of Persistent Asset Partners LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 1,309 shares of REGN stock, worth $822,052. This represents 0.51% of its overall portfolio holdings.
Number of Shares
1,309
Previous 6,980
81.25%
Holding current value
$822,052
Previous $4.43 Billion
84.48%
% of portfolio
0.51%
Previous 3.71%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,443Shares Held
89MCall Options Held
1.77MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.92 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.3 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.55 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.03 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.4 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $67.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...